CVL-231 (Emraclidine)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for CVL-231 (Emraclidine), covering 2025-07-28 to 2026-08-21. Get the full timeline:
Most recent: Clinical Trial Results: A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia [Phase 2]